Search Results 81-90 of 18314 for Hepatitis C

  1. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

    To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...

  2. A Registry for Cirrhosis that has a Sustained Virologic Response Following Sofosbuvir-Based Treatment without Interferon, for Patients who have Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus study or commercially at selected sites. Once enrolled, the ...

  3. Ribavirin (oral route) - Side effects & dosage - Mayo Clinic

    For hepatitis C virus infection, in combination with peginterferon alfa-2b: For oral dosage form (capsules):. Adults—Dose is based on body weight and must be ...

  4. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled ...

  5. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...

  6. Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer

    ... hepatitis C infection. "The liver scarring from hepatitis C can take 20 to 30 years to develop into cancer," Dr. Kim says. "We're now seeing cancer patients ...

  7. 4/16/16 #MayoClinicRadio Podcast: Hep C, Food Allergies, Hemorrhoids - Mayo Clinic News Network

    On Mayo Clinic Radio, infectious diseases specialist Dr. Stacey Rizza outlines the risk factors for contracting hepatitis C, especially for people born between ...

  8. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...

  9. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    Patients chronically infected with Hepatitis C · Subjects who received a liver transplant, have chronic hepatitis C virus (HCV) recurrence and advanced fibrosis ...

  10. The epigenome as a link between the environment and human disease - Research - Mayo Clinic Research

    ... hepatitis C virus infection on Liver disease progression. This diagram elucidates how epigenetic changes due to environmental exposures such as hepatitis C ...